| Literature DB >> 21686326 |
Wei Tan1, Shengping Hou, Zhengxuan Jiang, Zheng Hu, Peizeng Yang, Jian Ye.
Abstract
PURPOSE: The gene for Eph-receptor tyrosinekinase-type A2 (EPHA2) has been shown to be involved in the pathogenesis of age-related cataract (ARC). The aim of this study was to examine whether EPHA2 polymorphisms were associated with the susceptibility to age-related cortical cataract in a Han Chinese population.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21686326 PMCID: PMC3115745
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Baseline characteristics of study participants.
| ARC patients | 422 | 183 (43.36) | 239 (56.64) | 63.58±6.76 | 50–89 |
| Controls | 317 | 149 (47.00) | 168 (53.00) | 61.92±6.03 | 50–83 |
ARC, age-related cortical cataract
Primers and restriction enzymes used for RFLP analysis of the EPHA2 gene.
| 5′-CAGCTTTCTGGAGTCTCAGTTTTATT-3′ | Tru1I | |
| | 5′-TCCCTACGTTATATGAGTACCC-3′ | |
| 5′-CCCGGCCACCAGAAGCGCAT-3′ | TasI | |
| | 3′-GACCTCGGGGTAGCCGGTTCTT-5′ | |
| 5′-ATAAAGATGTGGCTAGAGGT-3′ | AluI | |
| | 3′-TGCGTAAGTCGTTTCCACCT-5′ | |
| 5′-CTGATGTAGATGGGGTGCTG-3′ | HpyF10VI | |
| | 3′-TTTTACCTACACTCTCCGAC-5′ | |
| 5′-GGAGAATGGTTTTTAGGAAGCAACAT-3′ | Hsp92II | |
| 3′-TTATTTCAAAGGGGAGGACGGT-5′ |
Frequencies of genotypes and alleles of EPHA2 polymorphisms in ARC patients and controls.
| AA | 314 (74.41) | 210(66.25) | 5.845 | 0.016 | NS | 1.481 (1.076~2.039) | |
| | AC | 96 (22.75) | 99 (31.23) | 6.704 | 0.010 | NS | 0.648 (0.467~0.901) |
| | CC | 12 (2.84) | 8 (2.52) | 0.070 | 0.791 | NS | 1.130 (0.457~2.799) |
| | A | 724 (85.78) | 519 (81.86) | 4.162 | 0.041 | NS | 1.337 (1.011~1.768) |
| | C | 120 (14.22) | 115 (18.14) | 4.162 | 0.041 | NS | 0.748 (0.566~0.989) |
| CC | 301 (71.33) | 222 (70.03) | 0.147 | 0.702 | NS | 1.065 (0.773~1.466) | |
| | CT | 111 (26.30) | 84 (26.50) | 0.004 | 0.953 | NS | 0.990 (0.711~1.378) |
| | TT | 10 (2.37) | 11 (3.47) | 0.794 | 0.373 | NS | 0.675 (0.283~1.610) |
| | C | 713 (84.48) | 528 (83.28) | 0.386 | 0.534 | NS | 1.093 (0.826~1.445) |
| | T | 131 (15.52) | 106 (16.72) | 0.386 | 0.534 | NS | 0.915 (0.692~1.211) |
| AA | 260 (61.61) | 161 (50.79) | 8.649 | 0.003 | 0.045 | 1.555 (1.158~2.089) | |
| | AG | 135 (31.99) | 136 (42.90) | 9.281 | 0.002 | 0.030 | 0.626 (0.463~0.847) |
| | GG | 27 (6.40) | 20 (6.31) | 0.002 | 0.961 | NS | 1.015 (0.558~1.845) |
| | A | 655 (77.61) | 458 (72.24) | 5.607 | 0.018 | NS | 1.332 (1.050~1.689) |
| | G | 189 (22.39) | 176 (27.76) | 5.607 | 0.018 | NS | 0.751 (0.592~0.952) |
| TT | 218 (51.66) | 183 (57.73) | 2.687 | 0.101 | NS | 0.782 (0.583~1.049) | |
| | CT | 178 (42.18) | 122 (38.48) | 1.024 | 0.311 | NS | 1.166 (0.866~1.570) |
| | CC | 26 (6.16) | 12 (3.79) | 2.094 | 0.148 | NS | 1.669 (0.829~3.361) |
| | T | 614 (72.75) | 488 (76.97) | 3.404 | 0.065 | NS | 0.799 (0.629~1.014) |
| | C | 230 (27.25) | 146 (23.03) | 3.404 | 0.065 | NS | 1.252 (0.986~1.590) |
| GG | 302 (71.56) | 191 (60.25) | 10.430 | 0.001 | 0.015 | 1.660 (1.219~2.261) | |
| | CG | 110 (26.07) | 117 (36.91) | 9.999 | 0.002 | 0.030 | 0.603 (0.440~0.826) |
| | CC | 10 (2.37) | 9 (2.84) | 0.159 | 0.690 | NS | 0.831 (0.333~2.069) |
| | G | 714 (84.60) | 499 (78.71) | 8.537 | 0.003 | 0.015 | 1.486 (1.138~1.940) |
| C | 130 (15.40) | 135 (21.29) | 8.537 | 0.003 | 0.015 | 0.673 (0.515~0.879) |
OR, odds ratio; pc, Bonferroni corrected p value; NS, not significant.